Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.rmcr.2021.101502 http://scihub22266oqcxt.onion/10.1016/j.rmcr.2021.101502 34485048!8405236!34485048     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Respir+Med+Case+Rep 2021 ; 34 (ä): 101502 Nephropedia Template TP {{tp|p=34485048|t=2021. Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologic |pdf=|usr=}}{{34485048}} gab.com Text Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologic JO: Respir Med Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=34485048 #FOAvip Post-COVID-19 infection symptoms such as mental fog, tachycardia, and extreme fatigue are just a few of the symptoms wreaking havoc on patients' lives. Patients with long-term symptoms following COVID-19 are being called long haulers. To date, long haulers are receiving little to no guidance from physicians on their lingering COVID-19 symptoms with limited treatment options available. Zofin is an acellular biologic that contains the extracellular vesicle (EV) fraction of human amniotic fluid and is under investigation for use as a COVID-19 therapeutic. We obtained FDA and IRB approval to investigate the therapeutic use of Zofin in a single long hauler patient case experiencing prolonged shortness of breath and respiratory impairment. Administration of the EV product was shown to be safe. Furthermore, demonstrated respiratory improvements through chest X ray images and oxygen saturation measurement. The single patient IND studies were completed without any reported adverse events or safety concerns. Furthermore, these completed studies demonstrate the feasibility and a therapeutic potential of amniotic fluid-derived EVs for COVID-19 long hauler intervention. Twit Text FOAVip Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologic ????Respir Med Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=34485048 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34485048 #FOAvip English Wikipedia <ref>{{Cite pmid|34485048}}</ref> Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologic #MMPMID34485048 Mitrani MI; Bellio MA; Meglin A; Khan A; Xu X; Haskell G; Arango A; Shapiro GC Respir Med Case Rep 2021[]; 34 (ä): 101502 PMID34485048show ga Post-COVID-19 infection symptoms such as mental fog, tachycardia, and extreme fatigue are just a few of the symptoms wreaking havoc on patients' lives. Patients with long-term symptoms following COVID-19 are being called long haulers. To date, long haulers are receiving little to no guidance from physicians on their lingering COVID-19 symptoms with limited treatment options available. Zofin is an acellular biologic that contains the extracellular vesicle (EV) fraction of human amniotic fluid and is under investigation for use as a COVID-19 therapeutic. We obtained FDA and IRB approval to investigate the therapeutic use of Zofin in a single long hauler patient case experiencing prolonged shortness of breath and respiratory impairment. Administration of the EV product was shown to be safe. Furthermore, demonstrated respiratory improvements through chest X ray images and oxygen saturation measurement. The single patient IND studies were completed without any reported adverse events or safety concerns. Furthermore, these completed studies demonstrate the feasibility and a therapeutic potential of amniotic fluid-derived EVs for COVID-19 long hauler intervention. äTreatment of a COVID-19 long hauler with an amniotic fluid-derived ext(epmc).pdf DeepDyve Pubget Overpricing